| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Dimension Capital I, L.P. | 8.7% | +12% | $88,799,995 | +$14,201,407 | 5,663,265 | +19% | Adam Goulburn | 31 Dec 2025 |
| BIOTECHNOLOGY VALUE FUND L P | 9.2% | +29% | $29,545,889 | +$6,613,333 | 5,660,132 | +29% | BVF PARTNERS L P/IL | 31 Mar 2025 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 7.5% | $34,360,615 | 4,637,060 | T. Rowe Price Associates, Inc. | 30 Sep 2025 | |||
| TCG Crossover GP II, LLC | 7.2% | $32,812,836 | 4,427,705 | Chen Yu | 10 Oct 2025 | |||
| BlackRock, Inc. | 6.3% | $20,045,661 | 3,840,165 | BlackRock, Inc. | 31 Dec 2024 | |||
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5.5% | $17,539,200 | 3,360,000 | SUVRETTA CAPITAL MANAGEMENT, LLC | 09 Apr 2025 | |||
| VANGUARD GROUP INC | 4.8% | -6% | $22,148,142 | -$1,240,441 | 2,988,953 | -5.3% | The Vanguard Group | 30 Sep 2025 |
| Versant Venture Capital VI, L.P. | 3.4% | -34% | $35,080,976 | -$17,220,640 | 2,236,708 | -33% | Versant Venture Capital VI, L.P. | 07 Jan 2026 |
| FMR LLC | 2.8% | $7,072,953 | 1,750,731 | FMR LLC | 30 May 2025 |
As of 30 Sep 2025, 126 institutional investors reported holding 60,027,627 shares of Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GLUE). This represents 92% of the company’s total 65,095,000 outstanding shares.
The largest institutional shareholders of Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GLUE) together control 83% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 12% | 7,692,298 | 0% | 3.1% | $56,999,928 |
| BVF INC/IL | 8.7% | 5,660,132 | 0% | 1.7% | $41,941,578 |
| Versant Venture Management, LLC | 8.7% | 5,652,922 | 0% | 20% | $41,888,152 |
| BAKER BROS. ADVISORS LP | 7.6% | 4,916,095 | 0% | 0.26% | $36,428,264 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 7.1% | 4,637,060 | -27% | 0% | $34,362,000 |
| BlackRock, Inc. | 5.9% | 3,815,133 | -0.81% | 0% | $28,270,135 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5.2% | 3,360,000 | 0% | 0.75% | $24,897,600 |
| VANGUARD GROUP INC | 4.6% | 2,988,953 | -4.8% | 0% | $22,148,142 |
| FMR LLC | 4.3% | 2,812,251 | +23% | 0% | $20,838,780 |
| Aisling Capital Management LP | 2.3% | 1,472,331 | 0% | 2.4% | $10,909,973 |
| Alphabet Inc. | 2.2% | 1,464,015 | 0% | 0.45% | $10,848,351 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.8% | 1,151,566 | +2.4% | 0% | $8,534,702 |
| MARSHALL WACE, LLP | 1.4% | 902,834 | +102% | 0.01% | $6,690,001 |
| STATE STREET CORP | 1.3% | 846,773 | +1.8% | 0% | $6,274,588 |
| Vestal Point Capital, LP | 1.2% | 800,000 | 0.27% | $5,928,000 | |
| NORTHERN TRUST CORP | 1.1% | 740,684 | -2.7% | 0% | $5,488,469 |
| AQR CAPITAL MANAGEMENT LLC | 1.1% | 717,262 | -44% | 0% | $5,314,912 |
| Parkwood LLC | 1.1% | 708,000 | 0% | 0.51% | $5,246,000 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1.1% | 694,942 | 0.75% | $5,149,520 | |
| MORGAN STANLEY | 0.99% | 645,196 | +13% | 0% | $4,780,904 |
| DIMENSIONAL FUND ADVISORS LP | 0.97% | 632,182 | +41% | 0% | $4,683,844 |
| AMERICAN CENTURY COMPANIES INC | 0.91% | 593,394 | +47% | 0% | $4,397,050 |
| MILLENNIUM MANAGEMENT LLC | 0.68% | 444,939 | +588% | 0% | $3,296,998 |
| ROYAL BANK OF CANADA | 0.67% | 435,767 | -7.2% | 0% | $3,229,000 |
| Balyasny Asset Management L.P. | 0.63% | 408,540 | 0.01% | $3,027,281 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 187,480 | $2,947,108 | +$2,045,377 | $15.68 | 13 |
| 2025 Q3 | 60,027,627 | $444,802,878 | -$4,386,129 | $7.41 | 126 |
| 2025 Q2 | 62,196,889 | $280,514,086 | +$11,963,150 | $4.51 | 115 |
| 2025 Q1 | 59,523,717 | $276,191,314 | -$11,913,266 | $4.64 | 105 |
| 2024 Q4 | 60,988,332 | $423,262,031 | +$79,110,231 | $6.94 | 104 |
| 2024 Q3 | 49,754,753 | $263,674,421 | +$18,158,687 | $5.30 | 80 |
| 2024 Q2 | 45,836,316 | $171,427,053 | +$21,976,071 | $3.74 | 73 |
| 2024 Q1 | 39,892,581 | $281,249,822 | -$731,896 | $7.05 | 67 |
| 2023 Q4 | 40,102,427 | $226,575,690 | -$10,023,054 | $5.65 | 71 |
| 2023 Q3 | 42,042,126 | $201,382,486 | +$10,940,133 | $4.79 | 70 |
| 2023 Q2 | 39,734,743 | $272,184,520 | -$3,199,539 | $6.85 | 67 |
| 2023 Q1 | 39,769,032 | $309,801,540 | -$11,077,618 | $7.79 | 69 |
| 2022 Q4 | 41,325,746 | $314,458,629 | +$7,213,706 | $7.61 | 66 |
| 2022 Q3 | 40,353,101 | $329,604,037 | -$3,246,200 | $8.17 | 70 |
| 2022 Q2 | 38,778,221 | $374,994,819 | -$11,927,308 | $9.67 | 56 |
| 2022 Q1 | 39,943,480 | $559,876,587 | +$42,034,475 | $14.02 | 52 |
| 2021 Q4 | 36,340,047 | $741,974,000 | +$28,074,571 | $20.42 | 53 |
| 2021 Q3 | 34,892,057 | $759,420,127 | +$60,728,601 | $22.28 | 54 |
| 2021 Q2 | 32,095,195 | $705,074,000 | +$705,074,000 | $22.70 | 48 |